Phase II study of ABV (doxorubicin with increased dose, bleomycin and vinblastine) therapy in newly diagnosed advanced-stage Hodgkin lymphoma: Japan Clinical Oncology Group study (JCOG9705)

Michinori Ogura, Kuniaki Itoh, Kenichi Ishizawa, Yukio Kobayashi, Kensei Tobinai, Tomohiro Kinoshita, Masami Hirano, Ryuzo Ueda, Taro Shibata, Shigeo Nakamura, Kunihiro Tsukasaki, Tomomitsu Hotta, Masanori Shimoyama, Yasuo Morishima

    Research output: Contribution to journalArticlepeer-review

    5 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'Phase II study of ABV (doxorubicin with increased dose, bleomycin and vinblastine) therapy in newly diagnosed advanced-stage Hodgkin lymphoma: Japan Clinical Oncology Group study (JCOG9705)'. Together they form a unique fingerprint.

    Medicine & Life Sciences